Abstract 110P
Background
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma with high metastatic propensity and is often diagnosed at advanced stages, raising public health concerns in its endemic regions such as South China and Southeast Asia. The study of NPC metastasis is hindered by the lack of appropriate models capable to recapitulate the heterogeneous tumour microenvironment in vitro. The current study aims to generate an in vitro model to represent the in vivo biology for NPC and characterize the spheroid invasion in real time.
Methods
To mimic the microenvironment encountered by NPC cells in vivo, heterotypic multicellular tumour spheroids (MCTSs) consisting of triple co-culture of NPC cells (HK-1), fibroblasts (MRC-5), and endothelial cells (HUVEC) was generated using a scaffold-based method. Through histological and immunofluorescence analyses, the morphological characteristic and the organization of the MCTSs were characterized. Tumour spheroid migration assays were conducted on the extracellular matrix (ECM). Quantitative real-time measurements of migration and invasion through an ECM barrier of the MCTSs were conducted by using a real-time cell analyser.
Results
Heterotypic MCTSs constituted from HK-1, MRC-5, and HUVEC formed irregular mass and stellate morphology structure, with loosely arranged cells observed as revealed by H&E staining. The cells demonstrated tumour features including high chromatic and pleomorphism, high nuclear-to-cytoplasmic ratio, mitosis, and necrosis. Immunofluorescence staining showed the presence of NPC cells, fibroblasts, and endothelial cells in the heterotypic MCTSs. Through real-time cell monitoring, this heterotypic MCTSs showed migration and invasion at 1:10 Matrigel with 0.5 μg/μl fibronectin.
Conclusions
The three-dimensional model generated in this study successfully reconstructed the in vivo biology of NPC. To our knowledge, this is the first report on NPC spheroid model that incoporate both tumour and stromal cells. 3D co-culture spheroid is holding a great promise as next generation standard of in vitro pre-clinical model for biomarkers discovery, accelerating drug screening process, and achieving a more precise personalized treatment for cancer patients.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Fundamental Research Grant Scheme FRGS (FGRS/1/2020/SKK0/UCSI/02/2) by Ministry of Higher Education (MOHE) Malaysia.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
158P - Enhancing the communication of genomic results: Understanding patient and clinician perspectives
Presenter: Eleanor Johnston
Session: Cocktail & Poster Display session
Resources:
Abstract
159P - Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC
Presenter: Nathan Merrill
Session: Cocktail & Poster Display session
Resources:
Abstract
160P - CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
Presenter: Margaux BETZ
Session: Cocktail & Poster Display session
Resources:
Abstract
161P - PDL1 expression and its relation to EML4-ALK gene variants in metastatic lung adenocarcinoma: A single-center real-world experience
Presenter: Santhosh Meedimale
Session: Cocktail & Poster Display session
Resources:
Abstract
163P - Impact of genomic sequencing data on treatment decisions in advanced breast cancer (ABC)
Presenter: Sviatoslav Chekhun
Session: Cocktail & Poster Display session
Resources:
Abstract
164P - Clinical utility of comprehensive molecular profiling tests for advanced gastrointestinal tumors
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
165P - Evaluation of the mutational profile in patients with metastatic non-small cell lung carcinoma diagnosed in a tertiary hospital which was performed by NGS method
Presenter: Kankan Deka
Session: Cocktail & Poster Display session
Resources:
Abstract
166P - Targeted next-generation sequencing as reliable detection of genetic profile for cancer treatment to guide oncologists in Pakistan
Presenter: Zeeshan Ahmed
Session: Cocktail & Poster Display session
Resources:
Abstract
167P - Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute
Presenter: Andrea Torchia
Session: Cocktail & Poster Display session
Resources:
Abstract
168P - Usefulness of liquid biopsy in the management of patients with advanced or metastatic pancreatic cancer
Presenter: Jorge Iranzo Barreira
Session: Cocktail & Poster Display session
Resources:
Abstract